Sign in

CIK 0001346830

  • Non-accelerated filer
  • Smaller reporting company

Tvardi Therapeutics, Inc.

Sign in to watch
Ticker
TVRD
Exchange
Nasdaq
Industry
Pharmaceutical Preparations
FY end
Dec 31
Incorporated
DE
Entity type
Operating
Phone
+1 713-489-8654
Business address
3 SUGAR CREEK CTR. BLVD., STE 525, SUGAR LAND, TX, 77478
Former names
Cara Therapeutics, Inc., Cara Therapeutics Inc
Open-market buys, last 90 days
$0
in 0 filings
Open-market sales, last 90 days
$0
in 0 filings

Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.

Reading 100 more Form 4s from the SEC; this list fills in as they're read.

Date Insider Transaction Shares Price Value Owned after
2020-05-12 Ives Jeffrey L. Director Exercise or conversion +2,500 $9.94 $25K 8,500
2020-05-12 Ives Jeffrey L. Director Sale −2,500 $16.00 $40K 6,000
2020-05-12 Ives Jeffrey L. Director Exercise or conversion · Stock Option (Right to Buy) −2,500 1,000
2020-04-21 Ives Jeffrey L. Director Exercise or conversion +2,500 $9.94 $25K 8,500
2020-04-21 Ives Jeffrey L. Director Sale −2,500 $16.00 $40K 6,000
2020-04-21 Ives Jeffrey L. Director Exercise or conversion · Stock Option (Right to Buy) −2,500 3,500
2020-04-21 Terrillion Scott Sec'y; Chief Compliance & G.C. Sale −2,721 $15.56 $42K 38,382
2020-04-21 Menzaghi Frederique Ph.D. Chief Scientific Off,SVP-R&D Sale −12,894 $15.58 $201K 104,492
2020-04-21 CHALMERS DEREK T President & CEO Sale −6,348 $15.56 $99K 981,421
2020-04-17 Terrillion Scott Sec'y; Chief Compliance & G.C. Grant or award +8,334 41,103
2020-04-17 Menzaghi Frederique Ph.D. Chief Scientific Off,SVP-R&D Grant or award +37,500 117,386
2020-04-17 CHALMERS DEREK T President & CEO Grant or award +20,000 987,769
2020-03-04 Ives Jeffrey L. Director Exercise or conversion +2,500 $9.94 $25K 8,500
2020-03-04 Ives Jeffrey L. Director Sale −2,500 $16.00 $40K 6,000
2020-03-04 Ives Jeffrey L. Director Exercise or conversion · Stock Option (Right to Buy) −2,500 6,000
2020-02-24 Makara Richard VP, Head of Accting;Controller Grant or award · Employee Stock Option (Right to Buy) +30,000 30,000
2020-02-24 Terrillion Scott Sec'y; Chief Compliance & G.C. Grant or award +16,000 32,769
2020-02-24 Terrillion Scott Sec'y; Chief Compliance & G.C. Grant or award · Employee Stock Option (Right to Buy) +32,000 32,000
2020-02-24 Goncalves Joana Chief Medical Officer Grant or award +16,000 16,000
2020-02-24 Goncalves Joana Chief Medical Officer Grant or award · Employee Stock Option (Right to Buy) +32,000 32,000

Page 14 of 15 · 284 trades